{
      "brief_title": [
            "study",
            "oral",
            "relapse",
            "refractory",
            "diffuse",
            "large",
            "lymphoma"
      ],
      "brief_summary": [
            "study",
            "measure",
            "effectiveness",
            "side",
            "effect",
            "patient",
            "diffuse",
            "large",
            "lymphoma",
            "lymphoma"
      ],
      "condition": [
            "lymphoma"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [],
      "description": [
            "500",
            "mg",
            "oral",
            "daily",
            "six",
            "28",
            "day",
            "cycle"
      ],
      "other_name": [
            "enzastaurin"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "diagnosis",
            "recurrent",
            "refractory",
            "diffuse",
            "lymphoma",
            "adequate",
            "organ",
            "function",
            "able",
            "swallow",
            "capsule",
            "exclusion",
            "criterion",
            "3",
            "prior",
            "treatment",
            "disease",
            "serious",
            "heart",
            "problem"
      ],
      "gender": [],
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00042666.xml"
}